A STUDY COMPARING PHARMACOINVASIVE STRATEGY WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN YOUNG PATIENTS, INTENT TO DEFER STENTING

摘要

Background: Primary percutaneous coronary intervention (PCI) is the preferred treatment modality in patients with ST-Segment Elevation Myocardial Infarction (STEMI), due to established superior rates of infarct-related artery patency and TIMI 3 flow compared with thrombolytic therapy. In our study because higher rates of recanalization in young patients following thrombolytic therapy, we compared primary PCI versus pharmacoinvasive PCI in young patients Methods: Among 100 young patients (age < 40) with STEMI who presented within 12 hours after symptom onset, patients were randomly assigned to undergo either Primary PCI or fibrolytic therapy with streptokinase .coronary angiogram was performed with in 24 hour. The primary end point was composite of death, reinfarction up to six months.